Germany decriminalizes personal cannabis use, cultivation, and removes medical cannabis from narcotic list from April 1, 2024, benefiting MediPharm Labs.
Germany will decriminalize personal cannabis use and cultivation from April 1, 2024, and remove medical cannabis from its narcotic list. This change is expected to benefit Canadian pharmaceutical company, MediPharm Labs, whose wholly-owned subsidiary in Potsdam holds German GMP licenses for import, wholesale, and distribution of medical cannabis. The company anticipates accelerated growth in Germany due to the legalization.
March 25, 2024
4 Articles